Bipolar Disorder Integrative Staging: Incorporating Biomarkers Into Progression Across Stages

Summary

Bipolar disorder (BD) is a lifelong, recurrent condition with growing evidence supporting a neuroprogressive course, entailing the need to adopt staging models to guide stage-speci c interventions. Although different approaches have been proposed, their application remains limited and largely based on clinical features. BOARDING-PASS is an Italian government-funded, multicenter, prospective, and observational study aimed at advancing current knowledge of BD progression through the integration of clinical, biological, neuroimaging data, alongside machine learning (ML) methodologies. The study will enroll 120 subjects (age 18-70 years), classified according to the Kupka \& Hillegers' staging model, and recruited from three secondary-level psychiatric services in Italy. The primary outcome is the longitudinal assessment of clinical stage progression over an 18-month period, with evaluations conducted at baseline (T0), T1 (6 months), T2 (12 months), and T3 (18 months after baseline). At each time point, clinical variables will be collected, as well as clinical stages assigned. Additionally, at T0, T2, and T3, peripheral blood and unstimulated saliva samples will be collected to assess epigenetic regulation of gene expression - including DNA methylation, histone modi cations, and exosomal miRNAs - with a focus on key biomarkers such as C-reactive protein, proinflammatory cytokines, and BDNF, as well as microbial signatures of major oral bacterial phyla. Structural and resting state functional MRI scans will also be acquired at the same time points:structural data will be used to compute the structural connectome based on gyrification-based covariance networks, while resting-state data will be used to assess functional connectome alterations via graph theory metrics. Finally, all multimodal data will be integrated within a supervised ML algorithm based on Support Vector Machine, with the goal of developing a re ned, data-driven staging model for BD. BOARDING PASS project aligns with the growing need for a standardized, biologically informed staging framework that integrates clinical, inflammatory, epigenetic, and neuroimaging pro les to enhance prognostic accuracy and support tailored therapeutic interventions in BD.

Conditions

• Bipolar Disorder

Interventions

DIAGNOSTIC_TEST

psychometric clinical assessment

Clinical assessment will further include the administration of psychometric scales and questionnaires focused on clinical status, childhood trauma experiences, cognitive profile and adherence pattern

GENETIC

biological acquisition

Biological samples for gene expression, inflammation, and microbiome analyses will be collected at baseline, T2 and T3.

OTHER

neuroimaging data

MRI assessments will be performed using 3T scanners at T0, T2, and T3

Sponsors & Collaborators

• ASST Fatebenefratelli Sacco

  lead OTHER

Principal Investigators

• Bernardo Maria Dell'Osso · ASST Fatebenefratelli Sacco

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-11-08

Primary Completion

2026-05-20

Completion

2026-05-20

Countries

• Italy

Study Locations